Valuation: Cellink AB

Market Cap 1.01B 106M 91.93M 85.37M 78.73M 148M 10.1B 151M 396M 5.02B 397M 389M 16.88B P/E 2026 *
-6.3x
P/E 2027 * -33.7x
Enterprise Value 1.02B 107M 92.75M 86.13M 79.43M 150M 10.19B 152M 399M 5.06B 401M 392M 17.03B EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.52x
Free-Float
68.5%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 2023-11-26
Director of Finance/CFO 56 2026-02-28
Chief Operating Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 70 2019-12-17
Director/Board Member 65 2025-05-07
Chairman 51 2025-09-15
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 106M
-0.25%+0.20%+20.16%+4.53% 214B
-0.37%+1.52%-4.20%-23.38% 138B
-0.50%+5.94%-29.72%+8.43% 125B
-0.88%+5.98%-56.74%-10.93% 68.43B
+1.04%+3.61%+7.01%+5.82% 49.38B
-0.91%+9.32%-24.83%-29.57% 47.55B
-1.27%-1.03%+17.15%+13.57% 39.63B
+0.53%-0.25%+27.54%+38.10% 37.26B
-3.12%+12.17%-2.94%-10.85% 32.71B
Average -0.55%+7.11%-5.17%-0.47% 83.56B
Weighted average by Cap. -0.45%+7.53%-4.09%-1.96%

Financials

2026 *2027 *
Net sales 1.76B 185M 160M 149M 137M 259M 17.64B 264M 691M 8.76B 694M 679M 29.46B 1.9B 199M 173M 160M 148M 279M 18.98B 284M 743M 9.43B 747M 730M 31.7B
Net income -162M -17M -14.77M -13.72M -12.65M -23.83M -1.62B -24.26M -63.58M -806M -63.86M -62.46M -2.71B -29.21M -3.06M -2.66M -2.47M -2.28M -4.29M -292M -4.36M -11.44M -145M -11.49M -11.23M -488M
Net Debt 9M 942K 819K 760K 701K 1.32M 89.98M 1.34M 3.52M 44.69M 3.54M 3.46M 150M -20M -2.09M -1.82M -1.69M -1.56M -2.93M -200M -2.99M -7.83M -99.31M -7.87M -7.69M -334M
Logo Cellink AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-